Global Gastrointestinal Drug Trends in 2022
Gastrointestinal Drug is part of OTC. You may also be interested in Contraceptive, Oral Hygiene and Dietary Supplement.
Global antacid medicine sales are projected to reach $205 million by 2026, down 0.2% from 2021's $213 million. Average annual growth since 2016 has been 2.5%. South Korea had the highest sales in 2021, at $65 million, followed by Italy, Germany, and Chile. Austria saw a 20.8% year-on-year increase, while New Zealand experienced a 6% decrease since 2016.
Top 8 countries
In 2022 major markets in the Gastrointestinal Drug Industry were:
